Premium
Relationship between choline and apparent diffusion coefficient in patients with gliomas
Author(s) -
Khayal Inas S.,
Crawford Forrest W.,
Saraswathy Suja,
Lamborn Kathleen R.,
Chang Susan M.,
Cha Soonmee,
McKnight Tracy R.,
Nelson Sarah J.
Publication year - 2008
Publication title -
journal of magnetic resonance imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.563
H-Index - 160
eISSN - 1522-2586
pISSN - 1053-1807
DOI - 10.1002/jmri.21288
Subject(s) - effective diffusion coefficient , diffusion , choline , glioma , medicine , radiology , magnetic resonance imaging , physics , cancer research , thermodynamics
Purpose To examine the relationship between apparent diffusion coefficients (ADC) from diffusion weighted imaging (DWI) and choline levels from proton magnetic resonance spectroscopic imaging (MRSI) in newly diagnosed Grade II and IV gliomas within distinct anatomic regions. Materials and Methods A total of 37 patients with Grade II and 28 patients with Grade IV glioma were scanned on a 1.5T system with 3D MRSI and DWI. Region level analysis included Spearman rank correlation between median normalized ADC and choline for each patient per grade within each distinct abnormal anatomical region. Voxel level analysis calculated a Spearman rank correlation per region, per patient. Results Grade II lesions showed no evidence of a correlation between normalized ADC and choline using either the region or voxel level analysis. Region level analysis of Grade IV lesions did not appear to correlate in the contrast enhancement or necrotic core, but did suggest a significant negative correlation in the more heterogeneous nonenhancing and combined regions. Conclusion There appears to be differences in the relationship between ADC and choline levels in Grade II and Grade IV gliomas. Correlation within these regions in Grade IV lesions was strongest when all regions were included, suggesting heterogeneity may be driving the relationship. J. Magn. Reson. Imaging 2008;27:718–725. © 2008 Wiley‐Liss, Inc.